Immunotherapy in combination with chemotherapy vs. immunotherapy alone for advanced non-small cell lung cancer and programmed death ligand 1 score
Cancer Treatment and Research Communications · 2023
DOI: 10.1016/j.ctarc.2023.100769 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Cancer Treatment and Research Communications, 2023. Verfasst von Timothy T Pham und 4 weiteren Autor:innen. Beteiligte Einrichtung: Elevance Health, Indianapolis, IN, United States. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents, Immunological, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
INTRODUCTION: Little is known about the effectiveness of immunotherapy alone or with chemotherapy for patients with non-small cell lung cancer (NSCLC) and programmed death ligand 1 (PD-L1) expression
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Elevance Health, Indianapolis, IN, United States.
- Elevance Health, Indianapolis, IN, United States. Electronic address: Aliza.gordon@elevancehealth.com.
- Carelon Medical Benefits Management, Chicago, IL, United States.
Zitieren
APA
Pham, T. T., Gordon, A. S., Chen, X., Debono, D., & Fisch, M. J. (2023). Immunotherapy in combination with chemotherapy vs. immunotherapy alone for advanced non-small cell lung cancer and programmed death ligand 1 score. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2023.100769
Vancouver
Pham TT, Gordon AS, Chen X, Debono D, Fisch MJ. Immunotherapy in combination with chemotherapy vs. immunotherapy alone for advanced non-small cell lung cancer and programmed death ligand 1 score. Cancer Treatment and Research Communications. 2023. doi:10.1016/j.ctarc.2023.100769
BibTeX
@article{Pham2023,
author = {Pham, Timothy T and Gordon, Aliza S and Chen, Xiaoxue and Debono, David and Fisch, Michael J},
title = {Immunotherapy in combination with chemotherapy vs. immunotherapy alone for advanced non-small cell lung cancer and programmed death ligand 1 score},
journal = {Cancer Treatment and Research Communications},
year = {2023},
doi = {10.1016/j.ctarc.2023.100769}
}
EUVIMED